SPRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Spero Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.12+0.02 (+1.82%)
Close on Oct 19, 2026
- Market cap
- $64.92M
- P/E (TTM)
- 28.0
- Dividend yield
- –
SEC filings
40 of Spero Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 28, 2026 | Aug 28, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 8, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 23, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Jan 30, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 18, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2024 | Oct 29, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2024 | Sep 10, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | May 29, 2024 | Jun 3, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2024 | Apr 16, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 29, 2024 | Mar 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2024 | Mar 13, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 13, 2024 | SEC EDGAR |